doi: 10.1038/cddis.2016.132 20 OzmenHKErdemciBAskinSSezenO
(2025, December 8) GLP-1 drugs failed to slow Alzheimers in two big clinical trials
In fact, sample size estimates have indicated the need for a reasonable number of donors (n = 13299) to detect 2-fold changes in a panel of inflammatory readouts (e.g., IL-6 and IL-8 transcripts) to account for interindividual variability in studies using an in vitro primary cell-based model exposed to ozone ( in vitro assays (Moreau et al., 2022) by ideally using a broad set of different inhaled materials covering a diversity regarding chemical structures
These medications, including Zepbound and Wegovy, are generally designed for long-acting support, requiring only a once-weekly injection
Appropriate supplementation, when indicated based on individual assessment rather than routine use, can help address nutritional gaps during tirzepatide therapy
The renal effects of arGLP1 in patients with CKD have been evaluated in other studies